The Role of Phenoconversion in the Pharmacogenetics of Psychiatric Medication
Pharmacogenomics · 2023
DOI: 10.2217/pgs-2023-0100 ↗Kurz gefasst
Editorial in der Zeitschrift Pharmacogenomics, 2023. Verfasst von Martina Hahn und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Mental Health, Varisano Hospital Frankfurt Hoechst, Frankfurt, 65929, Germany. Hauptthemen laut MEDLINE: Pharmacogenetics, Mental Disorders. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 24 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Mental Health, Varisano Hospital Frankfurt Hoechst, Frankfurt, 65929, Germany.
- Department of Psychiatry, Psychosomatics & Psychotherapy, University Hospital Frankfurt - Goethe University, Frankfurt, 60528, Germany.
ORCID-Profile: Martina Hahn
Zitieren
APA
Hahn, M., & Roll, S. C. (2023). The Role of Phenoconversion in the Pharmacogenetics of Psychiatric Medication. Pharmacogenomics. https://doi.org/10.2217/pgs-2023-0100
Vancouver
Hahn M, Roll SC. The Role of Phenoconversion in the Pharmacogenetics of Psychiatric Medication. Pharmacogenomics. 2023. doi:10.2217/pgs-2023-0100
BibTeX
@article{Hahn2023,
author = {Hahn, Martina and Roll, Sibylle C},
title = {The Role of Phenoconversion in the Pharmacogenetics of Psychiatric Medication},
journal = {Pharmacogenomics},
year = {2023},
doi = {10.2217/pgs-2023-0100}
}
EUVIMED